跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,754 条关于
“BPL-24910”
全部
1,754
临床试验
1,198
药物
438
机构
14
资讯
104
去年
HHS and NIH Launch "Generation Gold Standard" Universal Vaccine Platform to Combat Pandemic Threats
11个月前
FDA Grants Breakthrough Therapy Designation to BPL-003 Nasal Spray for Treatment-Resistant Depression
6个月前
AtaiBeckley Advances BPL-003 to Phase 3 Trials for Treatment-Resistant Depression Following FDA Approval
去年
Atai Life Sciences Reports Mixed Phase 2b Results as BPL-003 Succeeds While Inidascamine Falls Short
7天前
Lilly Closes $2.8B AtaiBeckley Acquisition, Adding Rapid-Acting Neuroplastogen BPL-003 for Treatment-Resistant Depression
去年
5-MeO-DMT Nasal Spray Shows Promise in Phase 2a Alcohol Use Disorder Trial
去年
atai Life Sciences and Beckley Psytech Announce $390 Million Merger to Create Psychedelic Mental Health Leader
6个月前
AtaiBeckley Explores $2 Billion Deal for Psychedelic Depression Drug as Deutsche Bank Sees Major Market Potential
去年
atai Life Sciences Advances Psychedelic Therapy Pipeline with Key Clinical Milestones and Extended Financial Runway
上个月
Eli Lilly to Acquire AtaiBeckley for Up to $3.8 Billion in Landmark Psychedelic Medicine Deal
第 1 页,共 11 页
上一页
下一页